The benefits of higher IgM anti-PC levels for the reduction of CV risk were shown in younger patients, in males, and in the presence of obesity and if DAS28 remission was not achieved after 1 year. The gene discussed is CD40LG; the disease is obesity due to melanocortin 4 receptor deficiency.